If half of adults get COVID boosters at the new, higher prices, insurers, employers, and other payors would shell out $12.4 billion to $14.8 billion a year, a recent KFF report estimated.

The latest twist in a long-running dispute between the drug industry and insurers over which group is more to blame for rising costs to patients. And patients are, again, caught in the middle.

Judge Reed O'Connor of the U.S. District Court for the Northern District of Texas says one way that preventive services are selected for the no-cost coverage is unconstitutional.

Health insurers are posting their negotiated rates for just about every type of medical service they cover across all providers.

Tens of thousands of employers who buy insurance coverage for their workers will get this more-complete pricing picture — and may not like what they see.

The move by some insurers to cut commissions as of April 1 has caught the attention not only of brokers but of federal regulators.

At issue is a price transparency provision that requires giving patients detailed upfront cost estimates--including a diagnosis--before treatment.

A new provision would crack down on insurance brokers who have been enrolling people into ACA health plans without their consent.